216 related articles for article (PubMed ID: 24927133)
1. A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes.
Drake KM; Watson VG; Kisielewski A; Glynn R; Napper AD
Assay Drug Dev Technol; 2014 Jun; 12(5):258-71. PubMed ID: 24927133
[TBL] [Abstract][Full Text] [Related]
2. An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases.
Ibáñez G; McBean JL; Astudillo YM; Luo M
Anal Biochem; 2010 Jun; 401(2):203-10. PubMed ID: 20227379
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch.
Pham H; Kumar M; Martinez AR; Ali M; Lowery RG
SLAS Discov; 2024 Jun; 29(4):100161. PubMed ID: 38788976
[TBL] [Abstract][Full Text] [Related]
4. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function.
Lucio-Eterovic AK; Singh MM; Gardner JE; Veerappan CS; Rice JC; Carpenter PB
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16952-7. PubMed ID: 20837538
[TBL] [Abstract][Full Text] [Related]
5. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
6. Nizp1 is a specific NUP98-NSD1 functional interactor that regulates NUP98-NSD1-dependent oncogenic programs.
Berardi A; Botrugno OA; Quilici G; Manteiga JMG; Bachi A; Tonon G; Musco G
FEBS J; 2023 Apr; 290(7):1782-1797. PubMed ID: 36271682
[TBL] [Abstract][Full Text] [Related]
7. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
8. Covalent inhibition of NSD1 histone methyltransferase.
Huang H; Howard CA; Zari S; Cho HJ; Shukla S; Li H; Ndoj J; González-Alonso P; Nikolaidis C; Abbott J; Rogawski DS; Potopnyk MA; Kempinska K; Miao H; Purohit T; Henderson A; Mapp A; Sulis ML; Ferrando A; Grembecka J; Cierpicki T
Nat Chem Biol; 2020 Dec; 16(12):1403-1410. PubMed ID: 32868895
[TBL] [Abstract][Full Text] [Related]
9. The NSD1 and EZH2 overgrowth genes, similarities and differences.
Tatton-Brown K; Rahman N
Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):86-91. PubMed ID: 23592277
[TBL] [Abstract][Full Text] [Related]
10. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia.
Jaju RJ; Fidler C; Haas OA; Strickson AJ; Watkins F; Clark K; Cross NC; Cheng JF; Aplan PD; Kearney L; Boultwood J; Wainscoat JS
Blood; 2001 Aug; 98(4):1264-7. PubMed ID: 11493482
[TBL] [Abstract][Full Text] [Related]
11. Formulating a fluorogenic assay to evaluate S-adenosyl-L-methionine analogues as protein methyltransferase cofactors.
Wang R; Ibáñez G; Islam K; Zheng W; Blum G; Sengelaub C; Luo M
Mol Biosyst; 2011 Nov; 7(11):2970-81. PubMed ID: 21866297
[TBL] [Abstract][Full Text] [Related]
12. Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases.
Hsiao K; Zegzouti H; Goueli SA
Epigenomics; 2016 Mar; 8(3):321-39. PubMed ID: 26950288
[TBL] [Abstract][Full Text] [Related]
13. Assay development for histone methyltransferases.
Horiuchi KY; Eason MM; Ferry JJ; Planck JL; Walsh CP; Smith RF; Howitz KT; Ma H
Assay Drug Dev Technol; 2013 May; 11(4):227-36. PubMed ID: 23557020
[TBL] [Abstract][Full Text] [Related]
14. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
Qiao Q; Li Y; Chen Z; Wang M; Reinberg D; Xu RM
J Biol Chem; 2011 Mar; 286(10):8361-8368. PubMed ID: 21196496
[TBL] [Abstract][Full Text] [Related]
15. Design of a fluorescent ligand targeting the S-adenosylmethionine binding site of the histone methyltransferase MLL1.
Luan Y; Blazer LL; Hu H; Hajian T; Zhang J; Wu H; Houliston S; Arrowsmith CH; Vedadi M; Zheng YG
Org Biomol Chem; 2016 Jan; 14(2):631-638. PubMed ID: 26541578
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
Ettel M; Zhao L; Schechter S; Shi J
Pathology; 2019 Jun; 51(4):392-398. PubMed ID: 31060750
[TBL] [Abstract][Full Text] [Related]
17. Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia.
Barve A; Vega A; Shah PP; Ghare S; Casson L; Wunderlich M; Siskind LJ; Beverly LJ
Cells; 2019 Oct; 8(11):. PubMed ID: 31717699
[TBL] [Abstract][Full Text] [Related]
18. Detection and Quantification of Histone Methyltransferase Activity In Vitro.
Idigo NJ; Voigt P
Methods Mol Biol; 2022; 2529():43-61. PubMed ID: 35733009
[TBL] [Abstract][Full Text] [Related]
19. The NSD family of protein methyltransferases in human cancer.
Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
[TBL] [Abstract][Full Text] [Related]
20. Chemiluminescence Immunoassay for S-Adenosylhomocysteine Detection and Its Application in DNA Methyltransferase Activity Evaluation and Inhibitors Screening.
Li X; Meng M; Zheng L; Xu Z; Song P; Yin Y; Eremin SA; Xi R
Anal Chem; 2016 Sep; 88(17):8556-61. PubMed ID: 27464505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
